Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.
Transthyretin (TTR) is one of thirty non-homologous proteins whose misfolding, dissociation, aggregation, and deposition is linked to human amyloid diseases. Previous studies have identified that TTR amyloidogenesis can be inhibited through stabilization of the native tetramer state by small molecul...
Main Authors: | Satheesh K Palaninathan, Nilofar N Mohamedmohaideen, Elisabetta Orlandini, Gabriella Ortore, Susanna Nencetti, Annalina Lapucci, Armando Rossello, Joel S Freundlich, James C Sacchettini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2709434?pdf=render |
Similar Items
-
Antioxidant Quercetin 3-<i>O</i>-Glycosylated Plant Flavonols Contribute to Transthyretin Stabilization
by: Lidia Ciccone, et al.
Published: (2022-04-01) -
Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design
by: Lidia Ciccone, et al.
Published: (2020-01-01) -
Physiological Metals Can Induce Conformational Changes in Transthyretin Structure: Neuroprotection or Misfolding Induction?
by: Lidia Ciccone, et al.
Published: (2021-03-01) -
Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease
by: Lidia Ciccone, et al.
Published: (2023-07-01) -
Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption
by: Elisabete Ferreira, et al.
Published: (2021-12-01)